Autolus Therapeutics plc - Special Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Autolus Therapeutics ASCO AUTO3 Data Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today to Dr. Lucinda Crabtree, Vice President Investor Relations. Thank you. Please go ahead.
Thank you. Good morning or good afternoon, everyone, and thank you for taking part in today's call on the ASCO AUTO3 data update. I am Lucinda Crabtree, Vice President of Investor Relations. With me today are Dr. Christian Itin, our Chairman and Chief Executive Officer; Dr. Robert Chen, our AUTO3 and Lymphoma Program lead; Dr. Vijay Reddy, our Chief Medical Officer; Dr. Nushmia Khokhar, our Vice President of Clinical Development; Brent Rice, our Chief Commercial Officer in the U.S.; and Andrew Oakley, our Chief Financial Officer.
Before we begin, turning to Slide 2, I would
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |